Drug recall · December 26, 2018
Absorica recall
Why: Subpotent Drug: Isotretinoin content results were lower than the specification limit obtained during routing product monitoring.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Absorica (Isotretinoin) Capsules 30 mg USP, 30 capsules (3x10 Prescription Packs) Rx only, Manufactured by: Galephar Pharmaceutical Research Inc. Humacao, PR 00792, Distributed by: Sun Pharmaceutical Industries Inc. Cranbury, NJ 08512, UPC 310631117313, NDC 10631-117-31 (carton) NDC10631-117-69 (prescription pack)
- Lots / codes
Lot: 17F28AA, Exp 1/2020
- Quantity
- 47,520 prescription packs
- Company
- Sun Pharmaceutical Industries, Inc., Cranbury, NJ
- Distribution
- Nationwide in the USA
- Initiated
- December 7, 2018 · Voluntary: Firm initiated
- Classified
- April 22, 2019
- Reported
- December 26, 2018
- Ended
- June 14, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Absorica
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.